E-prescribing grows.
- Published in:
- 2010
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2010 AND VI 45 AND IP 4
Results: 18
1
2
Policy watch. FDA information systems, Sentinel Initiative seek more timeiy drug safety information.
- Published in:
- 2010
- Publication type:
- Journal Article
3
Medication safety and reliability. New black box warning for clopidogrel: 'poor metabolizers' of the drug may remain at risk for heart attack, stroke, and cardiovascular death.
- Published in:
- 2010
- Publication type:
- Journal Article
4
Reducing cardiovascular risk in patients with type 2 diabetes: management of dyslipidemia.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Naproxcinod: a first-in-class cyclooxygenase-inhibiting nitric oxide donor for osteoarthritis pain.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
6
News capsules. SSRI escitalopram improves cognitive function recovery in recent stroke survivors.
- Published in:
- 2010
- Publication type:
- Journal Article
7
Hepatitis C.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 138
- Publication type:
- Article
8
E-prescribing grows.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 137
- Publication type:
- Article
9
FDA information systems, Sentinel Initiative seek more timely drug safety information.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 136
- By:
- Publication type:
- Article
10
New black box warning for clopidogrel: "Poor metabolizers" of the drug may remain at risk for heart attack, stroke, and cardiovascular death.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 135
- Publication type:
- Article
11
Reducing cardiovascular risk in patients with type 2 diabetes: management of dyslipidemia.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 124
- By:
- Publication type:
- Article
12
Naproxcinod: A first-in-class cyclooxygenase-inhibiting nitric oxide donor for osteoarthritis pain.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 116
- By:
- Publication type:
- Article
13
SSRI escitalopram improves cognitive function recovery in recent stroke survivors.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 115
- Publication type:
- Article
14
FDA actions in brief.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 114
- Publication type:
- Article
15
First-time generic approvals.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 114
- Publication type:
- Article
16
VPRIV.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 113
- Publication type:
- Article
17
Ampyra.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 113
- Publication type:
- Article
18
Pipeline preview.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 113
- Publication type:
- Article